Green anesthesia and sustainable operating rooms represent a transformative movement in perioperative care, focusing on minimizing environmental impact without compromising patient safety or clinical outcomes. This review examines the epidemiology, pathophysiology of environmental harm, risk factors, clinical implications, diagnosis of environmental footprints, treatment strategies, recent advances, and current guideline recommendations for sustainable practices in the operating room. Evidence-based approaches, including reduction of volatile anesthetic gases, waste segregation, and adoption of renewable energy, are discussed to inform clinicians about integrating sustainability into routine perioperative practice.
The environmental impact of healthcare, particularly in the operating room (OR), is a growing concern among clinicians and policymakers. Anesthesia practices are significant contributors to healthcare pollution, with volatile anesthetics and disposable materials generating substantial greenhouse gas emissions and waste. The concept of green anesthesia and sustainable ORs seeks to align perioperative care with broader environmental stewardship efforts, emphasizing efficient resource utilization, reduced emissions, and improved waste management. As the global burden of surgical procedures increases, it is imperative for healthcare professionals to adopt evidence-based, sustainable interventions to reduce the ecological footprint while maintaining high standards of patient care.
Globally, operating rooms account for up to 30% of hospital waste and 60% of a facility’s energy consumption. Anesthetic gases such as desflurane, sevoflurane, and nitrous oxide are potent greenhouse gases, with desflurane having a global warming potential (GWP) over 2,500 times that of carbon dioxide. In the United States alone, it is estimated that healthcare generates nearly 10% of national greenhouse gas emissions, with ORs representing a significant proportion. The rising number of surgeries and increased reliance on single-use devices portend an escalating environmental burden unless sustainable interventions are implemented.
The pathophysiology of environmental damage in anesthesia is multifaceted. Volatile anesthetic agents are minimally metabolized and are largely exhaled by patients into the atmosphere, where they persist and contribute directly to atmospheric warming and ozone depletion. Nitrous oxide, in particular, has a long atmospheric half-life and is a major contributor to stratospheric ozone depletion. Additionally, the reliance on single-use plastics and energy-intensive devices in the OR compounds the carbon footprint. Waste incineration releases dioxins and heavy metals, further affecting air and soil quality, and contributing to respiratory and environmental diseases in the wider community.
Key risk factors for high environmental impact in anesthesia and ORs include the routine use of high-GWP anesthetics, lack of proper scavenging systems, excessive reliance on disposable items, insufficient recycling infrastructure, and low awareness among clinicians regarding sustainable alternatives. Institutional factors such as outdated OR designs, poor ventilation systems, and inadequate staff training further exacerbate environmental harm. The absence of standardized protocols for waste segregation and anesthetic gas capture also contributes to increased emissions and resource wastage.
While the direct clinical features of environmental impact are not immediately evident at the individual patient level, the cumulative effects manifest as increased incidences of climate-sensitive diseases, respiratory illnesses, and ecological disruptions. Hospitals in regions with high levels of emissions may observe higher rates of asthma and allergic diseases among staff and patients. Furthermore, staff exposure to waste anesthetic gases has been associated with occupational health risks, including headaches, fatigue, and reproductive concerns, underscoring the need for robust monitoring and mitigation strategies.
Diagnosing the environmental footprint of anesthesia and ORs involves quantifying waste generation, monitoring anesthetic gas emissions, and assessing energy consumption. Life cycle assessments (LCA) are increasingly employed to evaluate the overall environmental impact of anesthetic choices and OR practices. Advanced monitoring systems can measure real-time emissions from scavenging systems and track waste segregation efficacy. Institutional audits and benchmarking against evidence-based sustainability metrics are critical for identifying areas for improvement and tracking progress over time.
The cornerstone of sustainable anesthesia is the adoption of low-flow anesthesia techniques, which significantly reduce volatile agent consumption. Choosing anesthetic agents with lower GWPs, such as sevoflurane over desflurane, can markedly reduce emissions. Implementation of robust gas scavenging and capture systems is essential. OR waste management can be improved through meticulous segregation, recycling, and reprocessing of single-use devices when possible. Transitioning to reusable surgical textiles and instruments, and adopting digital workflows to minimize paper waste, further enhance sustainability. Staff education and multidisciplinary collaboration are paramount to the successful implementation of these strategies.
Recent innovations include the development of anesthetic gas capture and destruction technologies, which can remove and neutralize exhaled volatile agents before atmospheric release. Emerging biodegradable materials for surgical drapes and devices are being trialed, offering reduced landfill burden. Solar-powered ORs, advanced LED lighting, and smart HVAC systems are increasingly being integrated into new hospital designs. Research into intravenous anesthesia regimens, such as total intravenous anesthesia (TIVA), provides alternatives with lower environmental impact. Digital anesthesia records and remote monitoring reduce paper use and streamline perioperative workflows.
Professional bodies, including the American Society of Anesthesiologists and the Association of Anaesthetists, advocate for the routine use of low-flow anesthesia, preferential selection of low-GWP agents, and comprehensive waste segregation protocols. Guidelines recommend regular staff training in sustainability practices, periodic environmental audits, and the establishment of green teams within hospitals to lead and monitor initiatives. Adoption of reusable devices, investment in energy-efficient infrastructure, and ongoing research into environmentally friendly anesthetic techniques are strongly encouraged to align clinical practice with sustainability goals.
Green anesthesia and sustainable operating rooms represent a critical evolution in perioperative care, balancing clinical excellence with environmental responsibility. A multidisciplinary, evidence-based approach encompassing technology adoption, practice modification, and ongoing education is essential for reducing the ecological footprint of surgical care. As research and innovation continue to advance, healthcare professionals play a pivotal role in championing sustainable practices that safeguard both patient health and planetary well-being.
1.
Inner Thoughts of Leonard Bernstein, the "Maestro".
2.
Mobile prostate cancer screening clinic can ID the disease in disadvantaged men
3.
No Survival Benefit Seen With Adjuvant Atezolizumab in TNBC
4.
Parents, teachers at Missouri school want answers after string of cancer diagnoses
5.
A promising medication could slow brain tumors in children.
1.
Future-Ready Cancer Screening: What Every Clinician Should Know in 2025
2.
Cancer Evolution and Therapeutic Resistance: Mechanisms, Clinical Insights, and Emerging Strategies
3.
Targeting Cancer Stem Cells in Solid Tumors: Mechanisms, Clinical Implications, and Therapeutic Advances
4.
Partial Gland Ablation in Prostate Cancer: Oncologic Outcomes in Intermediate-Risk Cases
5.
Generative AI for Adaptive Oncology Trial Design
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III
2.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
4.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
5.
Current Scenario of Cancer- The Incidence of Cancer in Men
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation